eq posts
FeedPosted Oct 28th 2008 10:25AM by Laurie Pasternack (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Google (GOOG), Yahoo! (YHOO), New York Times'A' (NYT), AMR Corp (AMR), UAL Corp (UAUA), Intuit Inc (INTU), Analyst initiations, Delta Air Lines (DAL), Andersons Inc (ANDE)
Analyst upgrades:
- Calyon upgraded major network carriers based on falling oil prices and capacity cuts. The analyst is positive over the next 12 months but cautious short-term given the uncertain economy, and volatile markets and oil prices. AMR Corp (NYSE: AMR) and Delta Air (NYSE: DAL) were upgraded to Add from Neutral and UAL Corp (NASDAQ: UAUA) was raised to Neutral from Reduce.
- Ryanair (NASDAQ: RYAAY) was upgraded at Citigroup to Buy from Hold.
- Boardwalk Pipeline (NYSE: BWP) was raised to Buy from Hold at Deutsche Bank.
- Cowen lifted Biogen Idec (NASDAQ: BIIB) to Outperform from Neutral.
- JP Morgan upgraded Choice Hotels (NYSE: CHH) to Neutral from Underweight following the better-than-expected Q3 report.
- Oppenheimer upgraded shares of Integra LifeSciences (NASDAQ: IART) to Outperform from Perform on valuation, the company's minimal exposure to economic conditions, and expectations for margin improvement and a rebound in organic growth.
Analyst downgrades:
Continue reading Analyst calls: AMR, DAL, UAUA, RYAAY, BIIB, SHW, EQ, INTU, NYT, GOOG, YHOO ...
Posted Mar 31st 2008 11:03AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades
MOST NOTEWORTHY: Auto & Truck Suppliers, Oplink Comm and The Wet Seal were today's noteworthy upgrades:
- Baird upgraded the Auto & Truck Suppliers sector to Market Overweight from Market Weight citing valuations, lowered expectations, industry dynamics and a potential bottom in economic indicators. The firm upgraded Accuride Corp (NYSE: ACW) and Magna International (MGA) to Outperform from Neutral.
- Merriman upgraded shares of Oplink Comm (NASDAQ: OPLK) to Neutral from Sell on valuation, as they believe Friday's sell-off fully reflects near-term operating concerns and that share price downside from here is limited.
- Cowen raised The Wet Seal (NASDAQ: WTSLA) to Outperform from Neutral and has increased confidence that the new management's operational changes and cost cutting initiatives will lead to EPS upside.
OTHER UPGRADES:
- BT Group (NYSE: BT) was raised to Equal Weight from Underweight at Morgan Stanley.
- Societe Generale raised Royal Dutch Shell (NYSE: RDS.A) to Buy from Hold and ENI SpA (NYSE: E) to Hold from Sell.
- Goldman raised Embarq (NYSE: EQ) to Neutral from Sell.
Posted Dec 18th 2007 11:16AM by Eric Buscemi (RSS feed)
Filed under: Analyst upgrades and downgrades, Adobe Systems (ADBE)
MOST NOTEWORTHY: Adobe, National Oilwell Varco and Cirrus Logic were today's noteworthy upgrades:
- Deutsche Bank upgraded shares of Adobe (NASDAQ:ADBE) to Buy from Hold following the strong Q4 results, as they believe the negative sentiment around the stock creates an attractive entry point.
- Calyon upgraded shares of National Oilwell Varco (NYSE:NOV) to Buy from Add on valuation, as they believe the market's reaction to the Grant Prideco (NYSE:GRP) acquisition was overly negative. They view GRP as a good strategic fit.
- Cirrus Logic (NASDAQ:CRUS) was upgraded to Buy from Hold at Jefferies on valuation, as they believe the risk/reward is attractive.
OTHER UPGRADES:
Posted Oct 17th 2007 11:00AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Apple Inc (AAPL), Analyst initiations
MOST NOTEWORTHY: The U.S. clean energy sector, MGI Pharma, Apple and Kosan Biosciences were today's noteworthy initiations:
- Morgan Stanley initiated the U.S. clean energy sector with an Attractive view. The analyst assumed coverage of First Solar (NASDAQ: FSLR), Fuel Tech (NASDAQ: FTEK) and SunPower Corporation (NASDAQ: SPWR) with Overweight ratings and EnerNOC, Inc (NASDAQ: ENOC) with an Underweight rating.
- Banc of America started shares of MGI Pharma (NASDAQ: MOGN) with a Buy rating and $45 target, as they expect sales growth in 2008 to be driven by Aquavan, which they view as an underappreciated asset, and potential survival data for Dacogen.
- Soleil believes Apple (NASDAQ: AAPL) could nearly double its PC market share to between 5.5% and 6% over the next five years. The firm started shares with a Buy rating and $200 target.
- Roth Capital initiated Kosan Biosciences (NASDAQ: KOSN) with a Buy rating and $10 target, as they are positive on the company's Hsp90 program and expect an NDA filing as early as 2009 in the relapsed-refractory settings.
OTHER INITIATIONS:
Posted Feb 12th 2007 11:30AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst upgrades and downgrades, Bad news, Boston Scientific (BSX)
MOST NOTEWORTHY: Embarq Corp (EQ) and Boston Scientific Corp (BSX) were today's most notable downgrades:
- Goldman Sachs downgraded Embarq Corp (NYSE: EQ) to Sell from Neutral based on valuation and potential margin dilution.
- Boston Scientific Corp (NYSE: BSX) was downgraded to Peer Perform from Outperform at Bear Stearns based on regulatory and competitive challenges.
OTHER DOWNGRADES:
- Despite expectations of strong Q4 results and 2007 guidance, Needham downgraded Garmin Ltd (NASDAQ: GRMN) to Hold from Buy based on valuation, as they believe the multiple the market is willing to give the stock is likely to decline as PNDs continue to increase as a percentage of revenue.
- Roth Capital downgraded China BAK Battery Inc (NASDAQ: CBAK) to Hold from Buy.
- DA Davidson downgraded Weyerhaeuser Co (NYSE: WY) to Neutral from Buy.
- BMO Capital Markets downgraded Brady Corp (NYSE: BRC) to Market Perform from Outperform.
- Wachovia downgraded Boyd Gaming Corp (NYSE: BYD) to Market Perform from Outperform, expecting weakness in 2007 from the Las Vegas locals market and Atlantic City.
- Penn National Gaming Inc (NASDAQ: PENN) was downgraded to Hold from Buy at Deutsche Bank citing valuation.
Analyst summaries provided by
TheFlyOnTheWall.com (subscription required).